ADHD evaluation and treatment options
Trouble organizing tasks or staying focused may reflect ADHD, poor sleep, anxiety, or another concern. An Ondoc licensed clinician can review your history and discuss treatment options and next steps; Insurance or $50 self-pay.
What your visit can cover
- Review symptom history, daily impairment, and possible alternative causes
- Discuss behavioral strategies and treatment options
- Identify whether formal testing or specialty ADHD care is needed
When to be seen in person
Complex diagnostic questions may require an in-person or specialist assessment.
About ADHD
ADHD involves a persistent pattern of inattention and/or hyperactivity and impulsivity that began in childhood and affects functioning in more than one setting. Adults may struggle with organization, time management and completing tasks. Sleep problems, anxiety, depression and other conditions can cause similar difficulties, so diagnosis relies on history and assessment rather than a single online test. Some Ondoc providers offer ADHD evaluation, stimulant or non-stimulant medication management, practical behavioral strategies, and specialist referrals when needed.
Stimulant and non-stimulant ADHD medication information
These catalog medicines include stimulant and non-stimulant options with different uses and considerations. Not all Ondoc providers prescribe controlled medications. Prescribing decisions depend on the treating clinician, clinical appropriateness, and applicable requirements. Off-label use means use outside FDA-approved labeling. Strengths are catalog entries, not dosing instructions.
- Mixed amphetamine salts (Adderall)5 mg · 7.5 mg · 10 mg · 12.5 mg · 15 mg · 20 mg · 30 mg
A stimulant medicine containing mixed amphetamine salts, FDA-approved for ADHD. It is a controlled substance; a clinician reviews cardiovascular history, other medicines, misuse risk and applicable requirements.
- Methylphenidate (Ritalin)5 mg · 10 mg · 20 mg
A stimulant medicine FDA-approved for ADHD. It is a controlled substance; a clinician reviews cardiovascular history, other medicines, misuse risk and applicable requirements.
- Atomoxetine (Strattera)10 mg · 18 mg · 25 mg · 40 mg · 60 mg · 80 mg · 100 mg
A non-stimulant medicine approved for ADHD in children age 6 and older and adults. Improvement builds over several weeks.
- Viloxazine ER (Qelbree)100 mg · 150 mg · 200 mg
An extended-release non-stimulant approved for ADHD in children age 6 and older and adults. Interactions and mood changes require review.
- Guanfacine ER (Intuniv)1 mg · 2 mg · 3 mg · 4 mg
A non-stimulant with FDA ADHD labeling for ages 6–17. Adult use is off-label; sleepiness and low blood pressure can occur.
- Clonidine ER (Kapvay)0.1 mg
An extended-release non-stimulant with FDA ADHD labeling for ages 6–17. Adult use is off-label; it can lower blood pressure and must not be stopped abruptly.
- Bupropion XL (Wellbutrin XL)150 mg · 300 mg
An antidepressant sometimes considered off-label for adult ADHD, especially with depression. It is not FDA-approved for ADHD and is unsuitable with seizure disorders or certain eating disorders.
Additional medication information
Educational options, not an offer of a prescription from every provider. No dose or ordering instruction is provided.
- Methylphenidate formulations
- ADHD-approved products include immediate-release, extended-release and transdermal formulations. They differ in duration and age labeling; formulations are not interchangeable dose for dose.
- Dexmethylphenidate formulations (Focalin / Focalin XR)
- Stimulant formulations FDA-approved for ADHD, with immediate- and extended-release options. Formulation and age labeling differ.
- Lisdexamfetamine (Vyvanse)
- A stimulant FDA-approved for ADHD in adults and children age 6 and older. It is a controlled medicine; inclusion does not establish availability from a particular provider.